checkAd

     117  0 Kommentare NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing - Seite 3

    Investor Relations Contact
    InvestorRelations@nls-pharma.com
    www.nlspharmaceutics.com

    Lesen Sie auch

    SOURCE: NLS Pharmaceutics AG



    View the original press release on accesswire.com


    The NLS Pharmaceutics Stock at the time of publication of the news with a raise of 0,00 % to 0,133USD on NYSE stock exchange (19. April 2024, 22:30 Uhr).

    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Accesswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing - Seite 3 ZÜRICH, SWITZERLAND / ACCESSWIRE / April 19, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer